论文部分内容阅读
本文报告采用在超声引导下经皮注射醋酸(PAI)治疗小于3cm、少于4个的小肝癌作为多种治疗的一部分,分析91例病人的预后。 治疗组分为5组,醋酸浓度分别为15％,20％,30％,40％,50％。其中男性64例,女性27例,年龄43～85岁(平均61岁)。Child A级62例,Child B级5例,Child C级24例。每次醋酸注射量肝癌直径1～3cm者为1～2ml,2～3cm者为2～5ml,PAI治疗每周2次,
This article reports the use of ultrasound-guided percutaneous injection of acetic acid (PAI) to treat small hepatocellular carcinomas less than 3 cm and less than 4 as part of a variety of treatments to analyze the prognosis of 91 patients. The treatment components were 5 groups, and the acetic acid concentrations were 15%, 20%, 30%, 40%, and 50%, respectively. There were 64 males and 27 females, aged 43-85 years (average 61 years). There were 62 Child A grades, 5 Child B grades, and 24 Child C grades. Each time the volume of acetic acid injection liver cancer 1 ~ 3cm were 1 ~ 2ml, 2 ~ 3cm were 2 ~ 5ml, PAI treatment 2 times a week,